期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | ACS Medicinal Chemistry Letters LetPub Score 7.3
50 ratings
Rate
Reputation 8.8 Influence 6.3 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | ACS Med. Chem. Lett. | ||||||||||||||||||||||||
ISSN | 1948-5875 | ||||||||||||||||||||||||
h-index | 52 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.90%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://pubs.acs.org/journal/amclct | ||||||||||||||||||||||||
在線稿件提交 | https://acs.manuscriptcentral.com/acs | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | American Chemical Society | ||||||||||||||||||||||||
主題領域 | CHEMISTRY, MEDICINAL | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 2010 | ||||||||||||||||||||||||
每年文章數 | 216每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 16.84% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1948-5875%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-8 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[ACS Medicinal Chemistry Letters] 的評論 | 撰寫評論 |
作者: QSKY2025 領域: 化学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-12-31 15:38:24 評論於 The review comments are not difficult to change, possibly because of the high level of innovation. Three weeks for the first decision, with two reviewers. Revised for two weeks, then no response after re-submission for three weeks. Urged the editor to accept directly. ![]() ![]() |
作者: August Eveline 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-09 17:01:09 評論於 Does the magazine accept review articles? ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:04:13 評論於 Issues related to experiments and writing articles ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:05:59 評論於 You may not provide the supplement, but you must have convincing reasons for the reviewers and editors ![]() ![]() |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 09:12:39 評論於 What questions do reviewers and journal editors typically ask? ![]() ![]() |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 08:33:08 評論於 Reviewers and journal editors are requesting that I conduct additional experiments. Do I have to do them? Is it mandatory? ![]() ![]() |
作者: 一条小凡晴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-05-24 16:53:18 評論於 Review speed: 1.0 | Submission acceptance rate: 75.0 Experience sharing: Just got 1 paper accepted, always think highly of ACS journals. The review speed is very fast, with initial review taking 2-3 weeks, and the feedback on revisions is constructive. The revised version was returned in 1 week, very efficient. The journal requires high novelty and biological activity of the articles, while not placing high demands on compound synthesis techniques and quantities ![]() ![]() |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us